Market revenue in 2023 | USD 142.0 million |
Market revenue in 2030 | USD 232.0 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.83% in 2023. Horizon Databook has segmented the Spain intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
The Spanish health system has a strong public provision sector that dominates the health care market, and a smaller fairly dependent private sector. The system guarantees universal coverage and free healthcare access to all Spanish nationals, regardless of economic situation.
According to NCBI, the 5 leading causes of death in Spain, in 2018, were ischemic heart disease (14.6%), Alzheimer disease and other dementias (13.6%), stroke (7.1%), chronic obstructive pulmonary disease (6.9%), and lung cancer (5.0%).
All the above are high chronic diseases requiring critical monitoring the regulated delivery of medicine. These factors in turn fuels the market for intravenous infusion pumps preferred for anticancerous, insulin, and pain management treatments. The Spanish Agency for Medicine and Health Products certifies and sets guidelines for the intravenous infusion pump devices in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into Spain intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account